Insider Trading Alert - HPQ, CBG, SYK, MJN And MEI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 17, 2013, 129 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $69.90 to $563,062,500.00.

Highlighted Stocks Traded by Insiders:

Hewlett-Packard (HPQ) - FREE Research Report

Lesjak Catherine A who is Evp & Cfo at Hewlett-Packard sold 8,745 shares at $26.77 on Dec. 17, 2013. Following this transaction, the Evp & Cfo owned 41,357 shares meaning that the stake was reduced by 17.45% with the 8,745-share transaction.

The shares most recently traded at $26.98, up $0.21, or 0.78% since the insider transaction. Historical insider transactions for Hewlett-Packard go as follows:

  • 4-Week # shares sold: 6,000
  • 12-Week # shares sold: 12,000
  • 24-Week # shares sold: 24,000

The average volume for Hewlett-Packard has been 16.2 million shares per day over the past 30 days. Hewlett-Packard has a market cap of $51.7 billion and is part of the technology sector and computer hardware industry. Shares are up 92.63% year-to-date as of the close of trading on Tuesday.

Hewlett-Packard Company and its subsidiaries provide products, technologies, software, solutions, and services to individual consumers, small-and medium-sized businesses (SMBs), and large enterprises, including customers in the government, health, and education sectors worldwide. The stock currently has a dividend yield of 2.16%. The company has a P/E ratio of 10.3. Currently there are 3 analysts that rate Hewlett-Packard a buy, 3 analysts rate it a sell, and 13 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HPQ - FREE

TheStreet Quant Ratings rates Hewlett-Packard as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including poor profit margins, weak operating cash flow and generally higher debt management risk. Get the full Hewlett-Packard Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CBRE Group (CBG) - FREE Research Report

Malek Frederic V who is Director at CBRE Group sold 20,000 shares at $24.77 on Dec. 17, 2013. Following this transaction, the Director owned 564,211 shares meaning that the stake was reduced by 3.42% with the 20,000-share transaction.

The shares most recently traded at $25.19, up $0.42, or 1.66% since the insider transaction. Historical insider transactions for CBRE Group go as follows:

  • 4-Week # shares sold: 66,913
  • 12-Week # shares sold: 66,913
  • 24-Week # shares sold: 107,078

The average volume for CBRE Group has been 3.1 million shares per day over the past 30 days. CBRE Group has a market cap of $8.3 billion and is part of the financial sector and real estate industry.

CBRE Group, Inc. operates as a commercial real estate services and investment company. The company's segments include Americas; Europe, Middle East and Africa (EMEA); Asia Pacific; Global Investment Management; and Development Services. Currently there are 4 analysts that rate CBRE Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBG - FREE

TheStreet Quant Ratings rates CBRE Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full CBRE Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 21,000 shares at $71.54 on Dec. 17, 2013. Following this transaction, the Director owned 11.3 million shares meaning that the stake was reduced by 0.19% with the 21,000-share transaction.

The shares most recently traded at $71.80, up $0.26, or 0.37% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Stryker Corporation has been 1.4 million shares per day over the past 30 days. Stryker Corporation has a market cap of $27.1 billion and is part of the health care sector and health services industry. Shares are up 30.7% year-to-date as of the close of trading on Tuesday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.7%. The company has a P/E ratio of 30.7. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mead Johnson Nutrition Company (MJN) - FREE Research Report

Golsby Stephen W who is Director at Mead Johnson Nutrition Company sold 10,000 shares at $82.68 on Dec. 17, 2013. Following this transaction, the Director owned 100,920 shares meaning that the stake was reduced by 9.02% with the 10,000-share transaction.

The shares most recently traded at $82.95, up $0.27, or 0.33% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition Company go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 10,500
  • 24-Week # shares sold: 50,525

The average volume for Mead Johnson Nutrition Company has been 1.5 million shares per day over the past 30 days. Mead Johnson Nutrition Company has a market cap of $16.8 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 25.95% year-to-date as of the close of trading on Tuesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.64%. The company has a P/E ratio of 26.8. Currently there are 5 analysts that rate Mead Johnson Nutrition Company a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Mead Johnson Nutrition Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Methode Electronics (MEI) - FREE Research Report

Reynolds Thomas D who is Sr. VP Worldwide Automotive at Methode Electronics sold 48,461 shares at $33.74 on Dec. 17, 2013. Following this transaction, the Sr. VP Worldwide Automotive owned 150,000 shares meaning that the stake was reduced by 24.42% with the 48,461-share transaction.

The shares most recently traded at $32.87, down $0.87, or 2.65% since the insider transaction. Historical insider transactions for Methode Electronics go as follows:

  • 12-Week # shares sold: 9,200
  • 24-Week # shares sold: 9,200

The average volume for Methode Electronics has been 496,100 shares per day over the past 30 days. Methode Electronics has a market cap of $1.3 billion and is part of the technology sector and electronics industry. Shares are up 238.48% year-to-date as of the close of trading on Tuesday.

Methode Electronics, Inc. engages in the design, manufacture, and marketing of components and subsystem devices worldwide. Its Automotive segment provides electronic and electro-mechanical devices and related products to automobile original equipment manufacturers. The stock currently has a dividend yield of 0.82%. The company has a P/E ratio of 27.6. Currently there are 3 analysts that rate Methode Electronics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MEI - FREE

TheStreet Quant Ratings rates Methode Electronics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Methode Electronics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Stocks Finish Higher After Release of Fed Minutes

Stocks Finish Higher After Release of Fed Minutes

General Electric's Stock Gets Routed as CEO Flannery Flubs Presentation

General Electric's Stock Gets Routed as CEO Flannery Flubs Presentation